摘要
目的:探讨SolitAct技术治疗急性大血管闭塞脑梗死的有效性和安全性。方法:回顾性分析2021年5月至2022年6月大理大学第一附属医院神经外科收治的48例急性大血管闭塞脑梗死患者的病历资料,统计分析患者一次开通率、术后出血率及术后3个月预后良好率。结果:SolitAct技术开通率达到87.50%,术后出血率为20.83%,术后3个月预后良好率为56.25%。结论:SolitAct技术治疗急性大血管闭塞所致脑梗死是一种安全、有效的血管内再通手段,在实现血管再通、改善患者预后方面具有一定优势。
Objective:To explore the efficacy and safety of the SolitAct technique in the treatment of acute large vessel occlusive ischemic stroke.Methods:A retrospective analysis was conducted on the medical records of 48 patients with acute large vessel occlusive ischemic stroke admitted to the department of neurosurgery in the First Affiliated Hospital of Dali University from May 2021 to June 2022.The analysis included the success rate of vessel recanalization,postoperative bleeding rate,and the rate of good prognosis at 3 months postoperatively.Results:The SolitAct technique achieved a vessel recanalization success rate of 87.50%,with a postoperative bleeding rate of 20.83%.The rate of good prognosis at 3 months postoperatively was 56.25%.Conclusion:The SolitAct technique is a safe and effective endovascular recanalization method for acute large vessel occlusive ischemic stroke.It demonstrates certain advantages in achieving vessel recanalization and improving patient prognosis.
作者
张文浩
杨增浩
张睿
段芃媛
张垒
程建杰
Zhang Wenhao;Yang Zenghao;Zhang Rui;Duan Pengyuan;Zhang Lei;Cheng Jianjie(Department of Neurosurgery,The First Affiliated Hospital of Dali University,Dali,Yunnan 671000,China)
出处
《大理大学学报》
2024年第4期32-35,共4页
Journal of Dali University
基金
云南省教育厅科学研究基金项目(2020J0590)。
关键词
脑梗死
颅内大血管闭塞
血管内介入治疗
ischemic stroke
intracranial large vessel occlusion
endovascular intervention treatment